3H]Phencyclidine interactions with the nicotinic acetylcholine receptor channel and its inhibition by psychotropic, antipsychotic, opiate, antidepressant, antibiotic, antiviral, and antiarrhythmic drugs
Eldefrawi, A.T.; Miller, E.R.; Murphy, D.L.; Eldefrawi, M.E.
Molecular Pharmacology 22(1): 72-81
1982
ISSN/ISBN: 0026-895X PMID: 6126805 Document Number: 185551
The binding of PCP binding. The high affinities that several kinds of drugs have for these nicotinic channel sites point to their relative nonspecificity and suggest that at therapeutic doses some of these drugs may have adverse effects on motor end-plate function.
Document emailed within 1 workday
Related Documents
Pascuzzo, G.J.; Akaike, A.; Maleque, M.A.; Shaw, K.P.; Aronstam, R.S.; Rickett, D.L.; Albuquerque, E.X. 1984: The nature of the interactions of pyridostigmine with the nicotinic acetylcholine receptor-ionic channel complex. I. Agonist, desensitizing, and binding properties Molecular Pharmacology 25(1): 92-101Ei-Fakahany, E.F.; Miller, E.R.; Abbassy, M.A.; Eldefrawi, A.T.; Eldefrawi, M.E. 1983: Alcohol modulation of drug binding to the channel sites of the nicotinic acetylcholine receptor Journal of Pharmacology and Experimental Therapeutics 224(2): 289-296
Rao, K.S.; Aracava, Y.; Rickett, D.L.; Albuquerque, E.X. 1987: Noncompetitive blockade of the nicotinic acetylcholine receptor-ion channel complex by an irreversible cholinesterase inhibitor Journal of Pharmacology and Experimental Therapeutics 240(1): 337-344
McKay, D.B.; Aronstam, R.S.; Schneider, A.S. 1985: Interactions of microtubule-active agents with nicotinic acetylcholine receptors. Relationship to their inhibition of catecholamine secretion by adrenal chromaffin cells Molecular Pharmacology 28(1): 10-16
Aguayo, L.G.; Warnick, J.E.; Maayani, S.; Glick, S.D.; Weinstein, H.; Albuquerque, E.X. 1982: Site of action of phencyclidine. IV. Interaction of phencyclidine and its analogues on ionic channels of the electrically excitable membrane and nicotinic receptor: implications for behavioral effects Molecular Pharmacology 21(3): 637-647
Lapchak, P.A.; Araujo, D.M.; Collier, B. 1990: Opiate receptor-mediated inhibition of acetylcholine release from mammalian brain: tissue- and species-dependence Progress in Clinical and Biological Research 328: 347-350
Fiekers, J.F. 1985: Interactions of edrophonium, physostigmine and methanesulfonyl fluoride with the snake end-plate acetylcholine receptor-channel complex Journal of Pharmacology and Experimental Therapeutics 234(3): 539-549
Johnson, D.S.; Martinez, J.; Elgoyhen, A.B.; Heinemann, S.F.; McIntosh, J.M. 1995: Alpha-Conotoxin Imi exhibits subtype-specific nicotinic acetylcholine receptor blockade: preferential inhibition of homomeric alpha 7 and alpha 9 receptors Molecular Pharmacology 48(2): 194-199
Shaw, K.P.; Aracava, Y.; Akaike, A.; Daly, J.W.; Rickett, D.L.; Albuquerque, E.X. 1985: The reversible cholinesterase inhibitor physostigmine has channel-blocking and agonist effects on the acetylcholine receptor-ion channel complex Molecular Pharmacology 28(6): 527-538
Gopalakrishnan, M.; Molinari, E.J.; Sullivan, J.P. 1997: Regulation of human alpha4beta2 neuronal nicotinic acetylcholine receptors by cholinergic channel ligands and second messenger pathways Molecular Pharmacology 52(3): 524-534
Raftery, M. 1985: Signals to and from the nicotinic acetylcholine receptor Alcohol and Drug Research 6(2-3): 69-71
Barkas, T.; Mauron, A.; Roth, B.; Ballivet, M. 1988: Molecular dissection of the nicotinic acetylcholine receptor Monographs in Allergy 25: 12-19
Wenningmann, I.; Dilger, J.P. 2001: The kinetics of inhibition of nicotinic acetylcholine receptors by (+)-tubocurarine and pancuronium Molecular Pharmacology 60(4): 790-796
Bolger, M.B.; Dionne, V.; Chrivia, J.; Johnson, D.A.; Taylor, P. 1984: Interaction of a fluorescent acyldicholine with the nicotinic acetylcholine receptor and acetylcholinesterase Molecular Pharmacology 26(1): 57-69
Sher, E.; Gotti, C.; Clementi, F. 1988: Acetylcholine nicotinic receptor: a key molecule for the pathogenesis of myasthenia gravis Annali Dell'istituto Superiore di Sanita 24(1): 103-116
Min, C.K.; Owens, J.; Weiland, G.A. 1994: Characterization of the binding of [3H]substance P to the nicotinic acetylcholine receptor of Torpedo electroplaque Molecular Pharmacology 45(2): 221-227
Kimura, M.; Kimura, I.; Kondoh, T.; Tsuneki, H. 1991: Noncontractile acetylcholine receptor-operated Ca++ mobilization: suppression of activation by open channel blockers and acceleration of desensitization by closed channel blockers in mouse diaphragm muscle Journal of Pharmacology and Experimental Therapeutics 256(1): 18-23
Clementi, F.; Sher, E. 1985: Antibody induced internalization of acetylcholine nicotinic receptor: kinetics, mechanism and selectivity European Journal of Cell Biology 37: 220-228
Wang, X.; Wang, Y.-h.; Liu, S.; Li, C. 2017: Construction of the brain-targeting drug carrier through imprinting of nicotinic acetylcholine receptor α7 Yao Xue Xue Bao 52(3): 488-493
Duvoisin, R.M.; Heinemann, S.F. 1993: Transcription control elements of the rat neuronal nicotinic acetylcholine receptor subunit alpha 3 Brazilian Journal of Medical and Biological Research 26(2): 137-150